| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y102-01009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a75e4864cdf59d5bbc51664b00356ddf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff6506765f54c3db08c362b8fb60f5ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f7187241f442a30e6f97a1d55e5e241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_168e41b3a612706814af237fccc51f64 |
| publicationDate |
2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018016474-A1 |
| titleOfInvention |
Method for assisting determination of hematological stage of childhood acute lymphoblastic leukemia |
| abstract |
Provided are a method for assisting the determination of hematological stage of childhood acute lymphoblastic leukemia (childhood ALL) and an extracorporeal diagnostic agent usable in the method. The method for assisting the determination of hematological stage of childhood ALL comprises: (1) a step for acquiring the mRNA quantity of Wilms' tumor gene 1 (WT1) in biological sample(s) comprising the peripheral blood and/or the bone marrow fluid of a subject; (2) a step for acquiring the mRNA quantity of GAPDH in the above sample(s); and (3) a step for calculating an index value necessary for assisting the determination on the basis of the ratio between the WT1 mRNA quantity and the GAPDH mRNA quantity that are acquired respectively in the above steps (1) and (2). |
| priorityDate |
2016-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |